Dr. Brian Cummings presented “Lipidomics as a Tool for the Prediction of Drug-Induced Behavioral Changes” to the Department of Drug Discovery and Development at Auburn University.
Dr. Murph published, “Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer.” Shelley B Hooks and Mandi M Murph. Future Med Chem. 2015 Aug 21:1-7. [Epub ahead of print] PMID: 26293348
Dr. Cory Momany receives a $66,450 grant from the National Institutes of Health, “From RNA Sequences to Tertiary Structure, Accurate Predictions Through Backbone K-trees,” as part of a joint DMS/NIGMS initiative to support research at the interface of the biological and mathematical sciences.
Dr. James Bruckner served as a peer reviewer for the “Toxicological Profile for 1-Bromopropane” for the U.S. ATSDR/Centers for Disease Control. The is a comprehensive document on the toxicology and environmental exposure to this chemical. The document serves as the basis for federal guidelines for maximum safe exposure levels.
Dr. Franklin is awarded a $150,000, two-year R03 grant titled “Bax, Caspases, and Oxidative Stress in the Aging Brain.”
Dr. Elder receives an award from Student National Pharmaceutical Association (SNPhA) on behalf of the College’s chapter for hosting an outstanding meeting for Regions 1 and 2.
As well, Dr. Elder and Vivia Hill-Silcott, diversity coordinator, were recognized as SNPhA advisors for the Region 1 and 2.
Dr. Pegan participated in a Science and Technology Assistance Team (STAT) assigned to assist the U.S. Army’s 25 Infantry Tropic Lighting Infantry during their Pacific Pathways Joint Australian-U.S. Exercise in Queensland, Australia.
Tasks performed included:
1) Identifying places where Science and Technology can assist the U.S. Soldier
2) Serving as a scientific translator between frontline U.S. forces and the numerous laboratories that comprise the U.S. Army Research Development and Engineering Command.
3) Building Science and Technology partnerships with Australian Forces
Dr. Murph published “Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma.” Murph MM, Jiang GW, Altman MK, Jia W, Nguyen DT, Fambrough JM, Hardman WJ, Nguyen HT, Tran SK, Alshamrani AA, Madan D, Zhang J, Prestwich GD. Bioorg Med Chem. 2015 Jul 2. pii: S0968-0896(15)00548-9. doi: 10.1016/j.bmc.2015.06.054. [Epub ahead of print]